"Fred Hutch Cancer Center" "Cures Start Here"

Preclinical Imaging: Grants and Publications

Descriptions for Grant Writers

Fred Hutchinson Cancer Center investigators who are writing grant applications and need descriptions of the Preclinical Imaging shared resource can find them on the Comparative Medicine CenterNet site. Descriptions of the overall Fred Hutch Shared Resources program are available on the main Shared Resources grant information page. 

Selected Publications Made Possible by Preclinical Imaging

We have contributed to many high quality publications. For more publications, contact us.

Ying Z, Beronja S. Embryonic barcoding of equipotent mammary progenitors functionally identifies breast cancer drivers. Cell Stem Cell. 2020;26(3):403-419.e4. doi: 10.1016/j.stem.2020.01.009
Jia D, Augert A, Kim D-W et al. Crebbp loss drives small cell lung cancer and increases sensitivity to HDAC inhibition. Cancer Discov. 2018;8(11):1422-1437. doi: 10.1158/2159-8290.CD-18-0385
Hudecek M, Sommermeyer D, Kosasih P et al. The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity. Cancer Immunol Res. 2015;3(2):125-35. doi: 10.1158/2326-6066.CIR-14-0127
Stromnes I, Schmitt T, Hulbert A et al. T cells engineered against a native antigen can surmount immunologic and physical barriers to treat pancreatic ductal adenocarcinoma. Cancer Cell. 2015;28(5):638-652. doi: 10.1016/j.ccell.2015.09.022
Provenzano PP, Cuevas C, Chang AE et al. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell. 2012;21(3):418-429. doi: 10.1016/j.ccr.2012.01.007